Literature DB >> 22484854

Delayed formation of FancD2 foci in glioma stem cells treated with ionizing radiation.

Enrico Cappelli1, Donatella Vecchio, Guido Frosina.   

Abstract

BACKGROUND: Glioblastoma multiforme (WHO grade IV) is a highly lethal brain tumor. Its malignancy is in part due to cell populations refractory to radiotherapy and chemotherapy, which in some patients display stem properties (glioma stem cells-GSC). We and others have recently shown that a major mechanism of resistance of GSC to therapies resides in their slow proliferation that in turn is linked to constitutive activation of the DNA damage response. FancD2, a central player of the Fanconi anemia pathway, is induced when replication forks stall at DNA damage sites.
METHODS: We have analyzed the kinetics of FancD2 induction in two glioma cell lines with pronounced (Borru) and poor (DR177) stem phenotypes, by fluorescence analysis of nuclear foci.
RESULTS: FancD2 activation was significantly delayed in Borru, consistent with the slow replication fork progression in these cells. On the contrary, no significant difference between Borru and DR177 was observed for pH2AX nuclear foci formation that hallmarks a number of DNA structure variations including double-strand breaks.
CONCLUSION: GSC display reduced FancD2 activation following radiation damage, most probably due to their elongated cell cycle.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484854     DOI: 10.1007/s00432-012-1217-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  13 in total

1.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.

Authors:  Toshiyasu Taniguchi; Irene Garcia-Higuera; Paul R Andreassen; Richard C Gregory; Markus Grompe; Alan D D'Andrea
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 2.  The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research.

Authors:  Feng Wan; Suojun Zhang; Ruifan Xie; Baocheng Gao; Benito Campos; Christel Herold-Mende; Ting Lei
Journal:  Brain Pathol       Date:  2010-02-05       Impact factor: 6.508

Review 3.  Frontiers in targeting glioma stem cells.

Authors:  Guido Frosina
Journal:  Eur J Cancer       Date:  2010-12-22       Impact factor: 9.162

4.  Comparative analysis of DNA repair in stem and nonstem glioma cell cultures.

Authors:  Monica Ropolo; Antonio Daga; Fabrizio Griffero; Mara Foresta; Gianluigi Casartelli; Annalisa Zunino; Alessandro Poggi; Enrico Cappelli; Gianluigi Zona; Renato Spaziante; Giorgio Corte; Guido Frosina
Journal:  Mol Cancer Res       Date:  2009-03-10       Impact factor: 5.852

5.  Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability.

Authors:  Massimo Bogliolo; Alex Lyakhovich; Elsa Callén; Maria Castellà; Enrico Cappelli; María J Ramírez; Amadeu Creus; Ricard Marcos; Reinhard Kalb; Kornelia Neveling; Detlev Schindler; Jordi Surrallés
Journal:  EMBO J       Date:  2007-02-15       Impact factor: 11.598

6.  Characterization of glioma stem cells through multiple stem cell markers and their specific sensitization to double-strand break-inducing agents by pharmacological inhibition of ataxia telangiectasia mutated protein.

Authors:  Alessandro Raso; Donatella Vecchio; Enrico Cappelli; Monica Ropolo; Alessandro Poggi; Paolo Nozza; Roberto Biassoni; Samantha Mascelli; Valeria Capra; Fotios Kalfas; Paolo Severi; Guido Frosina
Journal:  Brain Pathol       Date:  2012-02-21       Impact factor: 6.508

7.  BMI1 sustains human glioblastoma multiforme stem cell renewal.

Authors:  Mohamed Abdouh; Sabrina Facchino; Wassim Chatoo; Vijayabalan Balasingam; José Ferreira; Gilbert Bernier
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

8.  FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures.

Authors:  Fenghua Yuan; Jimmy El Hokayem; Wen Zhou; Yanbin Zhang
Journal:  J Biol Chem       Date:  2009-06-27       Impact factor: 5.157

Review 9.  How the fanconi anemia pathway guards the genome.

Authors:  George-Lucian Moldovan; Alan D D'Andrea
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

Review 10.  Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.

Authors:  Emma Bolderson; Derek J Richard; Bin-Bing S Zhou; Kum Kum Khanna
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

View more
  2 in total

Review 1.  Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?

Authors:  Juliana B Vilar; Markus Christmann; Maja T Tomicic
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

2.  Interpretation, stratification and evidence for sequence variants affecting mRNA splicing in complete human genome sequences.

Authors:  Ben C Shirley; Eliseos J Mucaki; Tyson Whitehead; Paul I Costea; Pelin Akan; Peter K Rogan
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-03-14       Impact factor: 7.691

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.